Ebru Yucel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ebru Yucel has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Atakan Tanacan
Perinatology Department Ankara Bilkent City Hospital Ankara Turkey
1 shared publication - Banu Derim Yeğen
Department of Gynecology Obstetrics, Eskişehir City Hospital, Eskişehir, Turkey
1 shared publication - Ece Aydoğdu
Department of Gynecology and Obstetrics, Eskişehir City Hospital, Eskişehir 26080, Turkey
1 shared publication - Mehmet Can Keven
Division of Perinatology, Department of Gynecology Obstetrics, Eskişehir City Hospital, Eskişehir, Turkey
1 shared publication - Zafer Bütün
Department of Perinatology, Eskisehir City Hospital, Eskişehir, Eskişehir, Türkiye, Eskişehir, Türkiye
1 shared publication
Latest Publications
- Open Access
- 1 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (15) , 5414
Fetal Pancreatic Circumference as a Predictor of Gestational Diabetes Mellitus During 75 g OGTT
Objectives: The objective of this study was to investigate the relationship between the simultaneous 75 g Oral glucose tolerance test (OGTT), gestational diabetes mellitus (GDM), and fetal pancreatic circumference at 24–28 weeks of gestation. Methods: This prospective case–control study was conducted between September 2024 and February 2025 at our perinatology clinic, which provides tertiary health care services. The correlation between the 75 g OGTT, GDM, and pancreatic circumference was assessed by comparing fetal pancreatic circumference between the groups with and without GDM at the time of diagnosis. Results: A total of 130 pregnant patients were recruited for this` study, with 64 patients forming the GDM group and 66 patients forming the control group. Fetal pancreas circumference (7.0 cm vs. 6.4 cm, p < 0.001), fetal pancreas circumference percentile (88.5 vs. 52, p < 0.001), and the rate of fetal pancreas size >90th percentile (15.6% vs. 3%, p < 0.001) were significantly higher in the GDM group compared to the control group. Conclusions: Although our findings demonstrate a statistically significant correlation between fetal pancreatic circumference and GDM, diagnostic performance remains modest. Therefore, fetal pancreatic circumference should be interpreted as a supportive marker, such as family history, rather than a definitive marker for identifying individuals at risk for GDM.
- 1 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (15) , 5414
Open AccessFetal Pancreatic Circumference as a Predictor of Gestational Diabetes Mellitus During 75 g OGTT
Objectives: The objective of this study was to investigate the relationship between the simultaneous 75 g Oral glucose tolerance test (OGTT), gestational diabetes mellitus (GDM), and fetal pancreatic circumference at 24–28 weeks of gestation. Methods: This prospective case–control study was conducted between September 2024 and February 2025 at our perinatology clinic, which provides tertiary health care services. The correlation between the 75 g OGTT, GDM, and pancreatic circumference was assessed by comparing fetal pancreatic circumference between the groups with and without GDM at the time of diagnosis. Results: A total of 130 pregnant patients were recruited for this` study, with 64 patients forming the GDM group and 66 patients forming the control group. Fetal pancreas circumference (7.0 cm vs. 6.4 cm, p < 0.001), fetal pancreas circumference percentile (88.5 vs. 52, p < 0.001), and the rate of fetal pancreas size >90th percentile (15.6% vs. 3%, p < 0.001) were significantly higher in the GDM group compared to the control group. Conclusions: Although our findings demonstrate a statistically significant correlation between fetal pancreatic circumference and GDM, diagnostic performance remains modest. Therefore, fetal pancreatic circumference should be interpreted as a supportive marker, such as family history, rather than a definitive marker for identifying individuals at risk for GDM.